Zimmer Biomet said Mark Bezjak, a named executive officer in the 2025 proxy statement, informed the company on January 8, 2026 that he will resign his employment, including all officer positions with the company and its affiliates, effective as of January 16, 2026.

1. 01

   Zimmer Biomet said Mark Bezjak, a named executive officer in the 2025 proxy statement, informed the company on January 8, 2026 that he will resign his employment, including all officer positions with the company and its affiliates, effective as of January 16, 2026.

2. 02

   The company disclosed that Mark Bezjak is resigning from his employment with the company and its affiliates, including all officer positions, to pursue another business opportunity.

3. 03

   Zimmer Biomet said that, as previously reported, Mark Bezjak ceased to be an executive officer of the company on July 1, 2025.

4. 04

   The company filed this resignation under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) as of January 12, 2026, and stated that the date of the earliest event reported in the filing is January 8, 2026.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.